<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский вестник детской хирургии, анестезиологии и реаниматологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2219-4061</issn><issn publication-format="electronic">2587-6554</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1567</article-id><article-id pub-id-type="doi">10.17816/psaic1567</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Case reports</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Клинические случаи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Prolonged venous hemodiafiltration and hemoperfusion with polymixin in fulminant meningococcal disease: A case report</article-title><trans-title-group xml:lang="ru"><trans-title>Использование продленной вено-венозной гемодиафильтрации и гемоперфузии с полимиксином при фульминантной менингококковой инфекции: клинический случай</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>在暴发性脑膜炎球菌感染中使用长时间静脉血液透析和多粘菌素血液灌流：临床病例研究</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2213-0477</contrib-id><contrib-id contrib-id-type="spin">1726-6155</contrib-id><name-alternatives><name xml:lang="en"><surname>Serednyakov</surname><given-names>Konstantin V.</given-names></name><name xml:lang="ru"><surname>Середняков</surname><given-names>Константин Владимирович</given-names></name><name xml:lang="zh"><surname>Serednyakov</surname><given-names>Konstantin V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Med.)</p></bio><email>spbny@yahoo.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2131-4813</contrib-id><contrib-id contrib-id-type="spin">2225-1630</contrib-id><name-alternatives><name xml:lang="en"><surname>Aleksandrovich</surname><given-names>Yurii S.</given-names></name><name xml:lang="ru"><surname>Александрович</surname><given-names>Юрий Станиславович</given-names></name><name xml:lang="zh"><surname>Aleksandrovich</surname><given-names>Yurii S.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci, (Med.), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci, (Med.), Professor</p></bio><email>Jalex1963@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1113-5296</contrib-id><contrib-id contrib-id-type="spin">8423-4294</contrib-id><name-alternatives><name xml:lang="en"><surname>Pshenisnov</surname><given-names>Konstantin V.</given-names></name><name xml:lang="ru"><surname>Пшениснов</surname><given-names>Константин Викторович</given-names></name><name xml:lang="zh"><surname>Pshenisnov</surname><given-names>Konstantin V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>д-р мед. наук, доцент</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Med.)</p></bio><email>Psh_K@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0427-7344</contrib-id><contrib-id contrib-id-type="spin">7458-6203</contrib-id><name-alternatives><name xml:lang="en"><surname>Konev</surname><given-names>Alexandr I.</given-names></name><name xml:lang="ru"><surname>Конев</surname><given-names>Александр Иванович</given-names></name><name xml:lang="zh"><surname>Konev</surname><given-names>Alexandr I.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.) </p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Med.)</p></bio><email>icdrkonev@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3366-4896</contrib-id><contrib-id contrib-id-type="spin">2744-2818</contrib-id><name-alternatives><name xml:lang="en"><surname>Ioffe</surname><given-names>Michail Ya.</given-names></name><name xml:lang="ru"><surname>Иоффе</surname><given-names>Михаил Яковлевич</given-names></name><name xml:lang="zh"><surname>Ioffe</surname><given-names>Michail Ya.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Med.)</p></bio><email>1964ioffe@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Pediatric Research and Clinical Center for Infectious Diseases under the Federal Medical Biological Agency</institution></aff><aff><institution xml:lang="ru">Детский научно-клинический центр инфекционных болезней Медико-биологического агентства</institution></aff><aff><institution xml:lang="zh">Pediatric Research and Clinical Center for Infectious Diseases under the Federal Medical Biological Agency</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Saint Petersburg State Pediatric Medical University</institution></aff><aff><institution xml:lang="ru">Санкт-Петербургский государственный педиатрический медицинский университет</institution></aff><aff><institution xml:lang="zh">Saint Petersburg State Pediatric Medical University</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2023-12-18" publication-format="electronic"><day>18</day><month>12</month><year>2023</year></pub-date><pub-date date-type="pub" iso-8601-date="2023-12-20" publication-format="electronic"><day>20</day><month>12</month><year>2023</year></pub-date><volume>13</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><issue-title xml:lang="zh"/><fpage>591</fpage><lpage>598</lpage><history><date date-type="received" iso-8601-date="2023-10-27"><day>27</day><month>10</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-11-13"><day>13</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2023,</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://rps-journal.ru/jour/article/view/1567">https://rps-journal.ru/jour/article/view/1567</self-uri><abstract xml:lang="en"><p>Fulminate meningococcal infection is one of the most formidable life-threatening conditions in children, accompanied by a high probability of complications and adverse outcomes, including disability, irreversible damage to the central nervous system, and death. The key link in the pathogenesis of this condition is the massive release of endotoxins by the pathogen and total damage to the endothelium of all vessels, which underlies the development of septic shock and all complications. The use of extracorporeal hemocorrection methods is one of the most effective methods of treating fulminate meningococcal infection; however, despite the undoubted therapeutic effect, they are not included in the recommendations of a high level of evidence and are rarely used in routine clinical practice and, in most cases, only in the terminal phase of the disease. The study presented the characteristics of the course of generalized meningococcal infection in a 7-year-old child, including intensive care measures. Particular attention was paid to assessing the severity of the condition and the effectiveness of extracorporeal hemocorrection methods. The child’s condition upon admission to the intensive care unit was 11 points according to the pSOFA scale, which indicated the presence of decompensated multiorgan dysfunction and was the basis for prolonged venovenous hemodiafiltration. Based on the results of the endotoxin activity assay (0.67 units), hemoperfusion with polymyxin was conducted. During therapy, the patient’s condition stabilized. Sixty-eight hours after admission, medical support for hemodynamics was discontinued, and the parameters of invasive mechanical ventilation were reduced. On day 7 of treatment, the patient was extubated, and the events of respiratory distress did not increase over time. On day 8 after admission, with full compensation of all vital functions following ischemic damage and deep necrosis of the tissues of the lower extremities, the patient was transferred to a multidisciplinary surgical hospital for further treatment. Early informed use of extracorporeal hemocorrection techniques contributes to the rapid regression of septic shock events and recovery of the patient, demonstrating the high efficacy of the methods used and the need for further multicenter randomized trials to routinely use these therapies in clinical practice.</p></abstract><trans-abstract xml:lang="ru"><p>Генерализованная фульминантная менингококковая инфекция — одно из наиболее грозных жизнеугрожающих состояний детского возраста, сопровождающихся высокой вероятностью развития осложнений и неблагоприятных исходов, вплоть до инвалидизации, необратимого поражения центральной нервной системы и гибели пациента. Ключевым звеном патогенеза данного состояния является массивный выброс эндотоксина возбудителя и тотальное повреждение эндотелия всех сосудов, что лежит в основе развития септического шока и всех осложнений. Одним из наиболее эффективных методов лечения генерализованной фульминантной менингококковой инфекции считается применение методов экстракорпоральной гемокоррекции, однако, несмотря на несомненный терапевтический эффект, до настоящего времени они не входят в рекомендации высокого уровня доказательности и достаточно редко используются в рутинной клинической практике, причем в большинстве случаев лишь в терминальную фазу заболевания. В статье продемонстрированы особенности течения генерализованной менингококковой инфекции у ребенка 7 лет, отражены все мероприятия интенсивной терапии. Особое внимание уделено оценке тяжести состояния и эффективности методов экстракорпоральной гемокоррекции. Оценка состояния ребенка при поступлении в отделение реанимации и интенсивной терапии по шкале pSOFA составила 11 баллов, что свидетельствовало о наличии декомпенсированной полиорганной дисфункции и стало основанием для проведения продленной вено-венозной гемодиафильтрации. На основании результатов теста активности эндотоксина, Endotoxin Activity Assay (0,67 у. е.) принято решение о проведении гемоперфузии с полимиксином. На фоне проводимой терапии достигнута стабилизация состояния пациента. Через 68 ч после поступления прекращена медикаментозная поддержка гемодинамики, снижены параметры инвазивной искусственной вентиляции легких. На седьмые сутки лечения пациент экстубирован, в динамике явления респираторного дистресса не нарастали. На восьмые сутки после поступления на фоне полной компенсации всех витальных функций в связи с ишемическим повреждением и глубокими некрозами тканей нижних конечностей пациент переведен в многопрофильный хирургический стационар для дальнейшего лечения. Раннее обоснованное применение методов экстракорпоральной гемокоррекции способствует быстрому регрессированию явлений септического шока и выздоровлению пациента, что свидетельствует о высокой эффективности используемых методик и необходимости дальнейших мультицентровых рандомизированных исследований с целью рутинного использования данных методов лечения в клинической практике.</p></trans-abstract><trans-abstract xml:lang="zh"><p>全身暴发性脑膜炎球菌感染是儿童期最危险的危及生命的疾病之一，极有可能出现并发症和不良后果，甚至致残、对中枢神经系统造成不可逆转的损害和死亡。该病症发病机制的关键环节是病原体内毒素的大量释放和所有血管内皮的完全损伤，是感染性休克和所有并发症发展的基础。治疗全身性暴发性脑膜炎球菌感染的最有效方法之一被认为是使用体外血液纠正法，然而，尽管其治疗效果毋庸置疑，但迄今为止，这些方法并未被列入高水平证据推荐中，而且在常规临床实践中也很少使用，在大多数情况下仅用于疾病的终末期。文章展示了一名7岁儿童全身感染脑膜炎球菌的病程特点，反映了所有重症监护措施。特别注意评估病情的严重程度和体外血液矫正方法的有效性。根据 pSOFA 量表，患儿入院时的重症监护室病情评估结果为11分，这表明患儿存在失代偿性多器官功能障碍，是进行长时间静脉血液透析滤过的基础。根据 Endotoxin Activity Assay 检测结果（0.67 uC），决定使用多粘菌素进行血液灌流。在治疗的背景下，病人的病情得到了稳定。入院68小时后，停止了对血液动力学的药物支持，减少了有创人工通气参数。在治疗的第七天，病人拔掉了气管插管；呼吸困难的动态变化没有增加。入院后第八天，在下肢组织缺血损伤和深度坏死导致所有生命功能完全恢复的情况下，患者被转到一家多学科外科医院接受进一步治疗。体外血液纠正方法的早期合理应用有助于脓毒性休克现象的迅速消退和患者的康复，这表明所使用的方法非常有效，需要进一步进行多中心随机试验，以便在临床实践中常规使用这些治疗方法。</p></trans-abstract><kwd-group xml:lang="en"><kwd>fulminate meningococcal infection</kwd><kwd>sepsis</kwd><kwd>septic shock</kwd><kwd>multiple organ failure</kwd><kwd>extracorporeal hemocorrection</kwd><kwd>outcome</kwd><kwd>case report</kwd><kwd>children</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>генерализованная фульминатная менингококковая инфекция</kwd><kwd>сепсис</kwd><kwd>септический шок</kwd><kwd>полиорганная дисфункция</kwd><kwd>экстракорпоральная гемокоррекция</kwd><kwd>исход</kwd><kwd>клинический случай</kwd><kwd>дети</kwd></kwd-group><kwd-group xml:lang="zh"><kwd>全身性暴发性脑膜炎球菌感染</kwd><kwd>败血症</kwd><kwd>脓毒性休克</kwd><kwd>多器官功能障碍</kwd><kwd>体外血液纠正</kwd><kwd>结果</kwd><kwd>临床病例</kwd><kwd>儿童</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Aleksandrovich YuS, Pshenisnov KV, Gordeev VI. Intensivnaya terapiya kriticheskikh sostoyanii u detei. Titova LA, editor. Saint Petersburg: N-L, 2014. 976 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Александрович Ю.С., Пшениснов К.В., Гордеев В.И. Интенсивная терапия критических состояний у детей / под ред. Л.А. Титовой. Санкт-Петербург: Н-Л, 2014. 976 с.</mixed-citation><mixed-citation xml:lang="zh">Aleksandrovich YuS, Pshenisnov KV, Gordeev VI. Intensivnaya terapiya kriticheskikh sostoyanii u detei. Titova LA, editor. Saint Petersburg: N-L, 2014. 976 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Yushchuk ND. Infektsionnye bolezni. Natsional’noe rukovodstvo. Kratkoe izdanie. Yushchuk ND, Vengerov YuYa, editors. Moscow: GEOTAR-Media, 2022. 848 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Ющук Н.Д. Инфекционные болезни. Национальное руководство. Краткое издание / под ред. Н.Д. Ющука, Ю.Я. Венгерова. Москва: ГЭОТАР-Медиа, 2022. 848 с.</mixed-citation><mixed-citation xml:lang="zh">Yushchuk ND. Infektsionnye bolezni. Natsional’noe rukovodstvo. Kratkoe izdanie. Yushchuk ND, Vengerov YuYa, editors. Moscow: GEOTAR-Media, 2022. 848 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Brady RC. Meningococcal infections in children and adolescents: update and prevention. Adv Pediatr. 2020;67:29–46. DOI: 10.1016/j.yapd.2020.03.007</mixed-citation><mixed-citation xml:lang="ru">Brady R.C. Meningococcal infections in children and adolescents: update and prevention // Adv Pediatr. 2020. Vol. 67. P. 29–46. DOI: 10.1016/j.yapd.2020.03.007</mixed-citation><mixed-citation xml:lang="zh">Brady RC. Meningococcal infections in children and adolescents: update and prevention. Adv Pediatr. 2020;67:29–46. DOI: 10.1016/j.yapd.2020.03.007</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Medeiros I, Reis Melo A, Baptista V, et al. Meningococcemia: rare but life-threatening. BMJ Case Rep. 2018;2018:bcr2018226914. DOI: 10.1136/bcr-2018-226914</mixed-citation><mixed-citation xml:lang="ru">Medeiros I., Reis Melo A., Baptista V., et al. Meningococcemia: rare but life-threatening // BMJ Case Rep. 2018. Vol. 2018. ID bcr2018226914. DOI: 10.1136/bcr-2018-226914</mixed-citation><mixed-citation xml:lang="zh">Medeiros I, Reis Melo A, Baptista V, et al. Meningococcemia: rare but life-threatening. BMJ Case Rep. 2018;2018:bcr2018226914. DOI: 10.1136/bcr-2018-226914</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Lekmanov AU, Mironov PI, Aleksandrovich YuS, et al. Sepsis in children: federal clinical guideline (draft). Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care. 2021;11(2):241–292. (In Russ.) DOI: 10.17816/psaic969</mixed-citation><mixed-citation xml:lang="ru">Лекманов А.У., Миронов П.И., Александрович Ю.С., и др. Сепсис у детей: федеральные клинические рекомендации (проект) // Российский вестник детской хирургии, анестезиологии и реаниматологии. 2021. Т. 11, № 2. С. 241–292. DOI: 10.17816/psaic969</mixed-citation><mixed-citation xml:lang="zh">Lekmanov AU, Mironov PI, Aleksandrovich YuS, et al. Sepsis in children: federal clinical guideline (draft). Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care. 2021;11(2):241–292. (In Russ.) DOI: 10.17816/psaic969</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">rospotrebnadzor.ru [Internet]. Gosudarstvennyi doklad «O sostoyanii sanitarno-ehpidemiologicheskogo blagopoluchiya naseleniya v RF v 2020 g.» MFS po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka [cited: 2023 Oct 24]. Available at: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=14933 (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">rospotrebnadzor.ru [Электронный ресурс]. Государственный доклад «О состоянии санитарно-эпидемиологического благополучия населения в РФ в 2020 г.» МФС по надзору в сфере защиты прав потребителей и благополучия человека [дата обращения: 24.10.2023]. Режим доступа: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=14933</mixed-citation><mixed-citation xml:lang="zh">rospotrebnadzor.ru [Internet]. Gosudarstvennyi doklad «O sostoyanii sanitarno-ehpidemiologicheskogo blagopoluchiya naseleniya v RF v 2020 g.» MFS po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka [cited: 2023 Oct 24]. Available at: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=14933 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Angus DC, Barnato AE, Bell D, et al. A systemic revive and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med. 2015;41(9):1549–1560. DOI: 10.1007/s00134-015-3822-1</mixed-citation><mixed-citation xml:lang="ru">Angus D.C., Barnato A.E., Bell D., et al. A systemic revive and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators // Intensive Care Med. 2015. Vol. 41, No. 9. Р. 1549–1560. DOI: 10.1007/s00134-015-3822-1</mixed-citation><mixed-citation xml:lang="zh">Angus DC, Barnato AE, Bell D, et al. A systemic revive and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med. 2015;41(9):1549–1560. DOI: 10.1007/s00134-015-3822-1</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Boeddha NP, Bycroft T, Nadel S, Hazelzet JA. The inflammatory and hemostatic response in sepsis and meningococcemia. Crit Care Clin. 2020;36(2):391–399. DOI: 10.1016/j.ccc.2019.12.005</mixed-citation><mixed-citation xml:lang="ru">Boeddha N.P., Bycroft T., Nadel S., Hazelzet J.A. The inflammatory and hemostatic response in sepsis and meningococcemia // Crit Care Clin. 2020. Vol. 36, No. 2. P. 391–399. DOI: 10.1016/j.ccc.2019.12.005</mixed-citation><mixed-citation xml:lang="zh">Boeddha NP, Bycroft T, Nadel S, Hazelzet JA. The inflammatory and hemostatic response in sepsis and meningococcemia. Crit Care Clin. 2020;36(2):391–399. DOI: 10.1016/j.ccc.2019.12.005</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Brandtzaeg P, van Deuren M. Classification and pathogenesis of meningococcal infections. In: Christodoulides M, editor. Neisseria meningitidis. Methods in Molecular Biology. Vol 799. Humana, Totowa, NJ, 2012. P. 21–35. DOI:10.1007/978-1-61779-346-2_2</mixed-citation><mixed-citation xml:lang="ru">Brandtzaeg P., van Deuren M. Classification and pathogenesis of meningococcal infections. In: Neisseria meningitidis. Methods in Molecular Biology. Vol 799. Christodoulides M., editor. Humana, Totowa, NJ, 2012. P. 21–35. DOI:10.1007/978-1-61779-346-2_2</mixed-citation><mixed-citation xml:lang="zh">Brandtzaeg P, van Deuren M. Classification and pathogenesis of meningococcal infections. In: Christodoulides M, editor. Neisseria meningitidis. Methods in Molecular Biology. Vol 799. Humana, Totowa, NJ, 2012. P. 21–35. DOI:10.1007/978-1-61779-346-2_2</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Zughaier SM. Neisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2. J Leukoc Biol. 2011;89(3):469–480. DOI: 10.1189/jlb.0610369</mixed-citation><mixed-citation xml:lang="ru">Zughaier S.M. Neisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2 // J Leukoc Biol. 2011. Vol. 89, No. 3. P. 469–480. DOI: 10.1189/jlb.0610369</mixed-citation><mixed-citation xml:lang="zh">Zughaier SM. Neisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2. J Leukoc Biol. 2011;89(3):469–480. DOI: 10.1189/jlb.0610369</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Darton T, Guiver M, Naylor S, et al. Severity of meningococcal disease associated with genomic bacterial load. Clin Infect Dis. 2009;48(5):587–594. DOI: 10.1086/596707</mixed-citation><mixed-citation xml:lang="ru">Darton T., Guiver M., Naylor S., et al. Severity of meningococcal disease associated with genomic bacterial load // Clin Infect Dis. 2009. Vol. 48, No. 5. P. 587–594. DOI: 10.1086/596707</mixed-citation><mixed-citation xml:lang="zh">Darton T, Guiver M, Naylor S, et al. Severity of meningococcal disease associated with genomic bacterial load. Clin Infect Dis. 2009;48(5):587–594. DOI: 10.1086/596707</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020;46(S1):10–67. DOI: 10.1007/s00134-019-05878-6</mixed-citation><mixed-citation xml:lang="ru">Weiss S.L., Peters M.J., Alhazzani W., et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children // Intensive Care Med. 2020. Vol. 46, No. S1. P. 10–67. DOI: 10.1007/s00134-019-05878-6</mixed-citation><mixed-citation xml:lang="zh">Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020;46(S1):10–67. DOI: 10.1007/s00134-019-05878-6</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Nishizaki N, Nakagawa M, Hara S, et al. Effect of PMX-DHP for sepsis due to ESBL-producing E. coli in an extremely low-birthweight infant. Pediatr Int. 2016;58(5):411–414. DOI: 10.1111/ped.12825</mixed-citation><mixed-citation xml:lang="ru">Nishizaki N., Nakagawa M., Hara S., et al. Effect of PMX-DHP for sepsis due to ESBL-producing E. coli in an extremely low-birthweight infant // Pediatr Int. 2016. Vol. 58, No. 5. P. 411–414. DOI: 10.1111/ped.12825</mixed-citation><mixed-citation xml:lang="zh">Nishizaki N, Nakagawa M, Hara S, et al. Effect of PMX-DHP for sepsis due to ESBL-producing E. coli in an extremely low-birthweight infant. Pediatr Int. 2016;58(5):411–414. DOI: 10.1111/ped.12825</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Yaroustovsky M, Abramyan M, Rogalskaya E, Komardina E. Selective polymyxin hemoperfusion in complex therapy of sepsis in children after cardiac surgery. Blood Purif. 2021;50(2):222–229. DOI: 10.1159/000510126</mixed-citation><mixed-citation xml:lang="ru">Yaroustovsky M., Abramyan M., Rogalskaya E., Komardina E. Selective polymyxin hemoperfusion in complex therapy of sepsis in children after cardiac surgery // Blood Purif. 2021. Vol. 50, No. 2. P. 222–229. DOI: 10.1159/000510126</mixed-citation><mixed-citation xml:lang="zh">Yaroustovsky M, Abramyan M, Rogalskaya E, Komardina E. Selective polymyxin hemoperfusion in complex therapy of sepsis in children after cardiac surgery. Blood Purif. 2021;50(2):222–229. DOI: 10.1159/000510126</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Aleksandrovich YuS, Serednyakov KV, Pshenisnov KV. Extracorporeal hemocorrection in complex therapy of septic shock in children. Russian Journal of Anesthesiology and Reanimatology. 2021;(4):110-117. (In Russ.) DOI: 10.17116/anaesthesiology2021041110</mixed-citation><mixed-citation xml:lang="ru">Александрович Ю.С., Середняков К.В., Пшениснов К.В. Экстракорпоральная гемокоррекция в комплексной терапии септического шока у детей // Анестезиология и реаниматология. 2021. № 4. С. 110–117. DOI: 10.17116/anaesthesiology2021041110</mixed-citation><mixed-citation xml:lang="zh">Aleksandrovich YuS, Serednyakov KV, Pshenisnov KV. Extracorporeal hemocorrection in complex therapy of septic shock in children. Russian Journal of Anesthesiology and Reanimatology. 2021;(4):110-117. (In Russ.) DOI: 10.17116/anaesthesiology2021041110</mixed-citation></citation-alternatives></ref></ref-list></back></article>
